Get the Stockscreener App
2.67
3.49%
0.09
After Hours:
2.68
0.01
+0.37%
Geovax Labs Inc stock is traded at $2.67, with a volume of 67,341.
It is up +3.49% in the last 24 hours and down -50.90% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$2.58
Open:
$2.54
24h Volume:
67,341
Relative Volume:
0.56
Market Cap:
$4.62M
Revenue:
$6.14M
Net Income/Loss:
$-24.81M
P/E Ratio:
-1.0723
EPS:
-2.49
Net Cash Flow:
$-27.40M
1W Performance:
-4.64%
1M Performance:
-50.90%
6M Performance:
-83.84%
1Y Performance:
-93.75%
1-Day Range:
$2.51
$2.715
1-Week Range:
$2.51
$2.90
52-Week Range:
$2.51
$47.12
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
2.67 | 4.47M | 6.14M | -24.81M | -27.40M | -2.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
Geovax Labs Inc Stock (GOVX) Latest News
Aug Swings: Will GeoVax Labs Inc outperform the market in YEARProfit Target & Long-Term Safe Investment Plans - baoquankhu1.vn
Valuation Update: Why is BLIV stock going downJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Can GeoVax Labs Inc. Equity Warrant outperform under higher oil pricesShare Buyback & Trade Opportunity Analysis - mfd.ru
Can GeoVax Labs Inc. Equity Warrant expand into new markets2025 Dividend Review & Precise Swing Trade Alerts - mfd.ru
Does GeoVax Labs Inc. Equity Warrant align with a passive investing strategyEarnings Summary Report & Weekly Setup with High ROI Potential - mfd.ru
Aug Levels: Does GeoVax Labs Inc Equity Warrant align with a passive investing strategyWeekly Investment Summary & Smart Swing Trading Alerts - baoquankhu1.vn
S P Trends: How cyclical is GeoVax Labs Inc Equity Warrants revenue streamShare Buyback & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Value Recap: What is the long term forecast for GeoVax Labs Inc. Equity Warrant stockPortfolio Update Summary & Weekly Sector Rotation Insights - baoquankhu1.vn
GOVX Stock Price, Forecast & Analysis | GEOVAX LABS INC (NASDAQ:GOVX) - Chartmill
GeoVax Labs announces public equity offering for liquidity - MSN
Geovax Labs (GOVX) Receives "Buy" Rating Again from D. Boral Cap - GuruFocus
Aug Macro: What is GeoVax Labs Incs revenue forecastEarnings Miss & AI Optimized Trading Strategy Guides - baoquankhu1.vn
GeoVax Identifies 2026 as Critical Year for Vaccine Development and Commercialization - citybuzz -
GeoVax Highlights 2026 as a Pivotal Year for Progress - Yahoo Finance
Published on: 2026-01-19 17:25:09 - baoquankhu1.vn
Sentiment Review: What analysts say about CHRW stock2025 Volatility Report & Fast Moving Trade Plans - baoquankhu1.vn
Moving Averages: What is Delek US Holdings Incs valuation compared to sectorQuarterly Portfolio Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Insider Sell: How much upside does GeoVax Labs Inc Equity Warrant have2025 Valuation Update & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
GeoVax Labs (GOVX) Price Target Increased by 2,400.00% to 237.15 - Nasdaq
Weekly Recap: How cyclical is GeoVax Labs Inc Equity Warrants revenue stream2025 Major Catalysts & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Published on: 2026-01-14 06:10:00 - Bộ Nội Vụ
Market Wrap: Why GeoVax Labs Inc. stock appeals to dividend seekersJuly 2025 Momentum & Risk Managed Investment Signals - Bộ Nội Vụ
GeoVax Labs Executes Reverse Stock Split and Charter Amendments - TipRanks
How GeoVax Labs Inc stock reacts to Fed rate cutsDividend Hike & Consistent Income Trade Recommendations - Bộ Nội Vụ
Why GeoVax Labs Inc. Equity Warrant stock could be next big winner2025 Bull vs Bear & Safe Entry Momentum Tips - Улправда
How GeoVax Labs Inc. stock benefits from strong dollarMarket Growth Report & Consistent Income Trade Ideas - Улправда
Will GeoVax Labs Inc. Equity Warrant stock split again soonBuy Signal & Daily Oversold Bounce Ideas - ulpravda.ru
What dividend safety score for GeoVax Labs Inc. Equity Warrant stockChart Signals & Low Drawdown Momentum Trade Ideas - Улправда
Is GeoVax Labs Inc. Equity Warrant stock safe for conservative investorsMarket Sentiment Summary & AI Powered Market Entry Ideas - Улправда
Is GeoVax Labs Inc. stock overvalued by current metricsTreasury Yields & Verified Swing Trading Watchlists - ulpravda.ru
How GeoVax Labs Inc. Equity Warrant stock reacts to inflationary pressuresCPI Data & Long-Term Capital Growth Ideas - Улправда
How currency fluctuations impact GeoVax Labs Inc. stockMarket Risk Report & Daily Entry Point Alerts - ulpravda.ru
Why GeoVax Labs Inc. stock remains undervalued2025 Market WrapUp & Stock Market Timing Techniques - Улправда
How GeoVax Labs Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Daily Stock Trend Watchlist - Улправда
Stop Loss: Why GeoVax Labs Inc. Equity Warrant stock remains a top recommendationWeekly Trend Recap & Smart Swing Trading Techniques - ulpravda.ru
Why GeoVax Labs Inc. Equity Warrant stock remains a top recommendation2025 Biggest Moves & Weekly Return Optimization Plans - Улправда
GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement - The Globe and Mail
Why GeoVax Labs Inc. stock is popular among millennials2025 Price Momentum & Daily Profit Focused Stock Screening - ulpravda.ru
GeoVax Labs: Dividend historical data and projections - MarketScreener
GeoVax Labs: Target Price Consensus and Analysts Recommendations | GOVX | US3736786068 - MarketScreener
GeoVax Labs: Performance & Quotes, GOVX Stock Price on Nasdaq Exchange - MarketScreener
GeoVax Labs: Financial Data Forecasts Estimates and Expectations | GOVX | US3736786068 - MarketScreener
Industry considering options amid US vaccine upheaval - BioWorld MedTech
How GeoVax Labs Inc. stock reacts to bond yieldsChart Pattern Recognition & Low Cost Capital Growth - bollywoodhelpline.com
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week - The Globe and Mail
GeoVax Labs to Outline Clinical Progress and Strategic Priorities at Major Healthcare Conferences - citybuzz -
About Us - FinancialContent
Why GeoVax Labs Inc. stock appeals to dividend seekers2026 world cup usa national team quarterfinals key players counter attacking expert forecast analysis - Улправда
GeoVax shareholders approve warrant exercises - MSN
GeoVax Labs (NASDAQ:GOVX) Shares Up 21.1% – Should You Buy? - Defense World
Is GeoVax Labs Inc a good long term investmentSupport Level Holds & Big Returns Small Capital - Early Times
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geovax Labs Inc Stock (GOVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SPENCER JOHN N JR | Director |
Apr 10 '25 |
Buy |
0.98 |
10,000 |
9,800 |
11,402 |
| Sharkey John W. | VP, Business Development |
Apr 10 '25 |
Buy |
0.99 |
6,000 |
5,940 |
6,191 |
| DODD DAVID A | President, CEO |
Apr 01 '25 |
Buy |
1.08 |
10,000 |
10,800 |
36,661 |
| Reynolds Mark | CFO |
Mar 31 '25 |
Buy |
1.08 |
6,800 |
7,343 |
14,013 |
0.23%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):